Elucidating the Dehydration Pathways of K2CO3·1.5H2O.

Potassium carbonate sesquihydrate has previously been identified as a promising material for thermochemical energy storage. The hydration and cyclic behavior have been extensively studied in the literature, but detailed investigation into the different processes occurring during dehydration is lacking. In this work, a systematic investigation into the different dehydration steps is conducted. It is found that at higher temperatures, dehydration of pristine material occurs as a single process since water removal from the pristine crystals is difficult. After a single cycle, due to morphological changes, dehydration now occurs as two processes, starting at lower temperatures. The morphological changes open new pathways for water removal at the newly generated edges, corners, and steps of the crystal surface. The observations from this work may contribute to material design as they elucidate the relation between material structure and behavior.

Testing Various Cement Formulations under Temperature Cycles and Drying Shrinkage for Low-Temperature Geothermal Wells.

Low-enthalpy geothermal wells are considered a sustainable energy source, particularly for district heating in the Netherlands. The cement sheath in these wells experiences thermal cycles. The stability of cement recipes under such conditions is not well understood. In this work, thermal cycling experiments for intermediate- and low-temperature geothermal well cements have been conducted. The samples were cured either under ambient conditions or under realistic pressure and temperature for 7 days. The samples did not show any signs of failure after performing 10 cycles of thermal treatment between 100 °C and 18 °C. We also tested cement formulations under drying conditions. Drying shrinkage is caused by a reduction in the water content of cement, which leads to capillary forces that can damage cement. Such circumstances lead to tensile stresses causing radial cracks. Most samples exhibited cracks under low humidity conditions (drying). Fiber reinforcement, especially using short PP fibers, improved the cement's resilience to temperature and humidity changes. Such additives can improve the longevity of cement sheaths in geothermal wells.

The Effect of Nanoconfinement on Deliquescence of CuCl2 Is Stronger than on Hydration.

The hydration of salts has gained particular interest within the frame of thermochemical energy storage. Most salt hydrates expand when absorbing water and shrink when desorbing, which decreases the macroscopic stability of salt particles. In addition, the salt particle stability can be compromised by a transition to an aqueous salt solution, called deliquescence. The deliquescence often leads to a conglomeration of the salt particles, which can block the mass and heat flow through a reactor. One way of macroscopically stabilizing the salt concerning expansion, shrinkage, and conglomeration is the confinement inside a porous material. To study the effect of nanoconfinement, composites of CuCl2 and mesoporous silica (pore size 2.5-11 nm) were prepared. Study of sorption equilibrium showed that the pore size had little or no effect on the onsets of (de)hydration phase transition of the CuCl2 inside the silica gel pores. At the same time, isothermal measurements showed a significant lowering of the deliquescence onset in water vapor pressure. The lowering of the deliquescence onset leads to its overlap with hydration transition for the smallest pores (<3.8 nm). A theoretical consideration of the described effects is given in the framework of nucleation theory.

Impact of Atmospheric CO2 on Thermochemical Heat Storage Capabilities of K2CO3.

This work investigates the reactions occurring in K2CO3-H2O-CO2 under ambient CO2 pressures in temperature and vapor pressure ranges applicable for domestic thermochemical heat storage. The investigation shows that depending on reaction conditions, the primary product of a reaction is K2CO3·1.5H2O, K2CO3·2KHCO3·1.5H2O, or a mixture of both. The formation of K2CO3·1.5H2O is preferred far above the equilibrium conditions for the hydration reaction. On the other hand, the formation of double salt is preferred at conditions where hydration reaction is inhibited or impossible, as the thermogravimetric measurements identified a new phase transition line below the hydration equilibrium line. The combined X-ray diffraction, thermogravimetric analysis, and Fourier-transform infrared spectroscopy study indicates that this transition line corresponds to the formation of K2CO3·2KHCO3, which was not observed in any earlier study. In view of thermochemical heat storage, the formation of K2CO3·2KHCO3·(1.5H2O) increases the minimum charging temperature by approximately 40 °C. Nevertheless, the energy density and cyclability of the storage material can be preserved if the double salt is decomposed after each cycle.

Absorption, Distribution, Metabolism, and Excretion of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Humans.

BACKGROUND: Aprocitentan is an orally active, dual endothelin receptor antagonist that may offer a new therapeutic option for the treatment of difficult-to-control hypertension. OBJECTIVE: To investigate safety, tolerability, mass balance, absorption, distribution, metabolism, and excretion of aprocitentan. METHODS: In this single-center, open-label study, a single oral dose of 25 mg containing 3.7 MBq of 14C-radiolabeled aprocitentan was administered to 6 healthy male subjects. Metabolites were identified using mass spectrometry and, where possible, confirmed and quantified with reference compounds. RESULTS: Aprocitentan was well tolerated and there were no clinically significant findings for any safety variable. The geometric mean cumulative recovery of radioactivity from urine and feces over 14 days was 77% of the administered radioactive dose, with 52.1% cumulative recovery from urine and 24.8% from feces. Concentrations of total radioactivity in whole blood were markedly lower compared to plasma. In plasma, 94.3% of total radioactivity was aprocitentan. In urine and feces, 5 and 2, respectively (in feces one being aprocitentan) main products were identified. Metabolism data of aprocitentan identified two main elimination pathways, glucosidation to M3 and hydrolysis to M1, representing approximately 25% and 32% of the radioactive dose, respectively. CONCLUSIONS: Based on these metabolism data, aprocitentan can be concomitantly administered without dose adjustment with drugs that are inhibitors or inducers of any metabolizing enzyme, specifically cytochrome P450 enzymes.

Absorption, distribution, metabolism, and excretion of cenerimod, a selective S1P1 receptor modulator in healthy subjects.

Cenerimod is a sphingosine-1-phosphate 1 receptor modulator under development for treatment of systemic lupus erythematosus.This single-centre, open-label, single-dose study investigated the mass balance and excretion routes and aimed at identifying and quantifying cenerimod metabolites in plasma, urine, and faeces after oral administration of 2 mg/100 µCi (3.7 MBq) of 14C-cenerimod.Total mean cumulative recovery was 84% of the administered dose (58-100% in faeces and 4.6-12% in urine). In a 0-504 h cross-subject area under the curve plasma pool, cenerimod and two metabolites were detected accounting for 78, 6.0, and 4.9% of total radioactivity, respectively, i.e. no major metabolite was identified in plasma. Cenerimod was only detected in faeces and accounted for 17% of the radioactivity excreted in this matrix. The metabolite M32 was detected in both urine and faeces and represented 23% and 66% of radioactivity excreted in these matrices, respectively. Other metabolites of unknown structure were detected in small amounts. Overall, M32 and cenerimod accounted for 52% and 13%, respectively, of the total radioactivity recovered.Among the excreted metabolites, only the non-enzymatically formed M32 represented more than 25% of total drug-related material. Therefore, no pharmacokinetic drug-drug interaction studies are foreseen.

Absorption, distribution, metabolism and excretion of the P2Y12 receptor antagonist selatogrel after subcutaneous administration in healthy subjects.

The P2Y12 receptor antagonist selatogrel which exhibits rapid inhibition of platelet aggregation following subcutaneous administration is in development for the treatment of acute myocardial infarction.This human ADME study was performed in six healthy male subjects to determine the routes of elimination and to identify/quantify the metabolites of selatogrel at a therapeutically relevant dose of 16 mg [14C]-radiolabelled selatogrel.The median tmax and t1/2 of selatogrel was 0.75 h and 4.7 h, respectively. It was safe and well tolerated based on adverse event, ECG, vital sign and laboratory data.Geometric mean total recovery of [14C]-radioactivity was 94.9% of which 92.5% was recovered in faeces and 2.4% in urine.Selatogrel was the most abundant entity in each matrix. In plasma, no major metabolite was identified. In excreta, the glucuronide M21 (14.7% of radioactivity) and the mono-oxidized A1 (6.2%) were the most abundant metabolites in urine and faeces, respectively.Overall, none of the metabolic pathways contributed to a relevant extent to the overall elimination of selatogrel, i.e. by more than 25% as defined per regulatory guidance. Hence, no pharmacokinetic interaction studies with inhibitors or inducers of drug-metabolizing enzymes are warranted for clinical development of selatogrel.

Metabolism of the Dual Orexin Receptor Antagonist ACT-541468, Based on Microtracer/ Accelerator Mass Spectrometry.

BACKGROUND: As part of an integrated and innovative approach to accelerate the clinical development of the dual receptor antagonist ACT-541468, 6 healthy subjects in one cohort in a first-in-humans (FIH) study received an oral dose of 50 mg non-labeled ACT-541468 together with a microtracer amount of 250 nCi of 14C-labeled ACT- 541468 to investigate its absorption, distribution, metabolism, and excretion (ADME). METHODS: Using accelerator mass spectrometry (AMS), radiochromatograms were constructed for fractionated plasma, urine, and feces samples. Subsequently, the structures of the metabolites were elucidated using high performance liquid chromatography (HPLC) coupled with high resolution mass spectrometry. RESULTS: In total 77 metabolites have been identified of which 30, 28, and 60 were present in plasma, urine, and feces, respectively. In plasma, the major metabolites were the mono-oxidized benzylic alcohol M3, the ACT-541468 aldehyde M1, formed by further oxidation of M3 in the benzylic position, and the doubly oxidized M10, formed by (1) benzylic oxidation of M3 (loss of one molecule of water and one molecule of ammonia) and (2) additional loss of water from the oxidized pyrrolidine ring of M5. Transformation of the pyrrolidine to a 6-membered ring was detected. Metabolites that accounted for more than 5% of total radioactivity in excreta were M2, which is also formed by oxidation at the benzylic position, M4, formed by demethylation of the methoxy-group, M7 and A6, both formed by oxidation of M4, and M10, the only major metabolite detected in urine. CONCLUSION: In conclusion, ACT-541468 is extensively metabolized predominantly by oxidative transformations.

The auditory ossicles as a DNA source for genetic identification of highly putrefied cadavers.

Genetic identification of putrefied bodies is a common task in forensic medicine. With advancing putrefaction, however, DNA integrity is rapidly decreasing and genetic typing of tissue might be impaired or impossible. Since DNA stability is generally higher in hard tissues, bones or teeth are frequently used as DNA source in such cases. However, isolation of DNA from hard tissues is usually very time-consuming and labor-intensive. This can be especially important in (forensic) cases where time is short and identification has to be carried out as fast as possible. Here, we present the identification of dead bodies by analyzing DNA from the auditory ossicles. These minuscule bones provided DNA of sufficient quality and quantity for identification purposes in all 40 investigated cases. Additionally, processing of the bones proved to be amazingly easy and fast, and a successful extraction is possible using a variety of different methods. We present a detailed protocol, results, and cases in which this new method has been successfully applied.

Saccadic eye movement performance as an indicator of driving ability in elderly drivers.

OBJECTIVE: Regular checking of the fitness to drive of elderly car-license holders is required in some countries, and this will become increasingly important as more countries face aging populations. The present study investigated whether the analysis of saccadic eye movements could be used as a screening method for the assessment of driving ability. METHODS: Three different paradigms (prosaccades, antisaccades, and visuovisual interactive (VVI) saccades) were used to test saccadic eye movements in 144 participants split into four groups: elderly drivers who came to the attention of road authorities for suspected lack of fitness to drive, a group of elderly drivers who served as a comparison group, a group of neurology patients with established brain lesion diagnoses, and a young comparison group. The group of elderly drivers with suspected deficits in driving skills also underwent a medical examination and a practical on-road driving test. The results of the saccadic eye tests of the different groups were compared. RESULTS: Antisaccade results indicated a strong link to driving behaviour: elderly drivers who were not fit to drive exhibited a poor performance on the antisaccade task and the performance in the VVI task was also clearly poorer in this group. CONCLUSIONS: Testing saccadic eye movements appears to be a promising and efficient method for screening large numbers of people such as elderly drivers. This study indicated a link between antisaccade performance and the ability to drive. Hence, measuring saccadic eye movements should be considered as a tool for screening the fitness to drive.

Development of flexible LEO-resistant PI films for space applications using a self-healing mechanism by surface-directed phase separation of block copolymers.

Polimide-block-polydimethylsiloxane (PI-b-PDMS) block copolymers have been synthesized from commercially available amino-terminated polysiloxanes with different molecular weights, for use as polymeric materials resistant to the low earth orbit (LEO) space environment. A structural optimization with respect to maximum environmental protection has been performed by varying the PDMS block length as well as the architecture of the block copolymers spanning from multiblock to triblock and star-shaped morphologies. The synthesized polymers and casted films show good mechanical and thermal performance. For block copolymers with a load of 2% PDMS (in the case of the multiblock copolymers), a complete surface coverage of the PDMS has been found. It has been shown that the transfer of the surface enriched PDMS layer into a thin silica layer after atomic oxygen (AO) exposure results in a drastic decrease in AO erosion rate. The silica layer protects the underlying material from oxygen initiated erosion resulting in a drastic decrease of surface roughness. This phenomena is observable for loads as small as 6 wt % PDMS.

1-Phenyl-1,2-cyclohexadiene: generation, interception by activated olefins, dimerisation and trimerisation.

Four possible precursors of 1-phenyl-1,2-cyclohexadiene (2) were examined, namely, 6,6-dibromo-1-phenylbicyclo[3.1.0]hexane, (1alpha,5alpha,6alpha)-6-bromo-6-fluoro-1-phenylbicyclo[3.1.0]hexane, 1-bromo-2-phenylcyclohexene and 1-bromo-6-phenylcyclohexene. All four compounds could be converted into 2, as demonstrated by the products of the interception of 2 with activated olefins. Styrene, 1,1-diphenylethene, indene, furan and 2,5-dimethylfuran were employed as such. Whereas the first three gave [2+2] cycloadducts of 2, the last two provided one [4+2] cycloadduct each. To create the [2+2] cycloadducts, the pi bond of 2 that is more remote from the phenyl group reacted, whereas the pi bond of 2 conjugated with the phenyl group exclusively produced the [4+2] cycloadducts. The generation of 2 in the absence of a trapping reagent brought about relatively good yields of a dimer or a trimer of 2 depending on the mode of the liberation of 2. Being derivatives of triphenylene, the dimer as well as the trimer have unusual structures, thereby indicating that a phenyl group is participating in the formation of these compounds. The most surprising structure of the trimer was elucidated by X-ray crystal diffraction. As to the mechanisms, diradical intermediates are proposed both for the cycloadditions and for the dimerisation. The initial steps of the latter seem to proceed also in the trimerisation.

1-Phenyl-1,2-cyclohexadiene: astoundingly high enantioselectivities on generation in a Doering-Moore-Skattebøl reaction and interception by activated olefins.

The resolution of (1alpha,5alpha,6alpha)-6-bromo-6-fluoro-1-phenylbicyclo[3.1.0]hexane (rac-5) provided the enantiomerically pure precursors (-)-5 and (+)-5 of 1-phenyl-1,2-cyclohexadiene. On treatment of (-)-5 with methyllithium in the presence of 2,5-dimethylfuran, the pure (-)-enantiomer of the [4+2] cycloadduct of 2,5-dimethylfuran onto 1-phenyl-1,2-cyclohexadiene was obtained exclusively. From this result, it is concluded that pure (M)-1-phenyl-1,2-cyclohexadiene ((M)-7) emerged from (-)-5 and was enantiospecifically intercepted to give the product. In the case of indene as trap for (M)-7, the (-)- and the (+)-enantiomer of the [2+2] cycloadduct were formed in the ratio of 95:5. Highly surprising, remarkable enantioselectivities were also observed, when (M)-7 was trapped with styrene to furnish two diastereomeric [2+2] cycloadducts. Hence, the achiral conformation of the diradical conceivable as intermediate cannot play a decisive part. The enantioselective generation of (M)- and (P)-7 by the beta-elimination route was tested as well. Accordingly, 1-bromo-2-phenylcyclohexene was exposed to the potassium salt of (-)-menthol in the presence of 2,5-dimethylfuran, and the enantiomeric [4+2] cycloadducts of the latter onto (M)- and (P)-7 were produced in the ratio of 55:45.